Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 1152-1156

  Natkunam, Yasodha ^a   Elenitoba Johnson, Kojo S ^b   Kingma, Douglas W ^b   Kamel, Onsi W ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ST JOHN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ARTICLE; BASE PAIRING; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENE DELETION; HUMAN; HUMAN CELL; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RHEUMATIC DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DERMATOMYOSITIS; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE AMPLIFICATION; GENE DELETION; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; POLYMERASE CHAIN REACTION; RHEUMATIC DISEASES; VIRAL MATRIX PROTEINS;

EID: 0030904153     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400621     Document Type: Article

References (30)

1. Kamel OW, van de Rijn M, Weiss L, del Zoppo GJ, Robbins BA, Montgomery PG, Warnke RA, Dorfman RF: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317-1321, 1993
2. Kamel OW, van de Rijn M, Lebrun DP, Weiss L, Warnke RA, Dorfman RF: Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638-643, 1994
3. Shiroky JB, Frost A, Skelton JD, Haegert DC, Newkirk MM, Neville C: Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 18:1172-1175, 1991
4. Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, Schultz M, Murren J: Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis. J Clin Oncol 14:1943-1949, 1996
5. Thomason RW, Craig FE, Banks PM, Sears DL, Myerson GE, Gulley ML: Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis. Mod Pathol 9:261-266, 1996
6. Kamel OW, Weiss LM, van de Rijn M, Colby TV, Kingma DW, Jaffe ES: Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease- in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol 20:1279-1287, 1996
7. Knecht H, Bachmann E, Brousset P, Bachmann F, Sandvej K, Odermatt BF: Latent membrane protein 1: a key oncogene in EBV-related carcinogenesis. Acta Haematol 90:167-171, 1993
8. Wang D, Leibowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840, 1985
9. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115, 1991
10. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409, 1991
11. Chen ML, Tsai CN, Liang CL, Shu CH, Hang CR, Sulitzeanu D, Liu ST, Chang YS: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140, 1992
12. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christenson B, Klein G, Winberg G: Clonability and tumorigenicity of human epithelial cells expressing the EBV-encoded membrane protein LMP-1. Oncogene 8:1575-1583, 1993
13. Knecht H, Bachmann E, Joske DJL, Sahli R, Emery-Goodman A, Casanova J-L, Ziliac M, Bachmann F, Odermatt BF: Molecular analysis of LMP oncogene in Hodgkin's disease. Leukemia 7:580-585, 1993
14. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937-2942, 1993
15. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF: Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523-528, 1995
16. Sculley TB, Apollini A, Hurren L, Moss DE, Cooper D: Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 162:643-648, 1990
17. Sculley TB, Cross SM, Borrow P, Cooper D: Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with human immunodeficiency virus. J Infect Dis 158: 186-192, 1988
18. Boyle MJ, Sewell WA, Sculley TB, Apollini A, Turner JJ, Swanson CE, Penny T, Cooper DA: Subtypes of Epslein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 81:3004-3011, 1993
19. Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, Esmore D, Sculley TB: Expression of B type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res 8:1869-1874, 1992
20. Chen WO, Chen YY, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM: Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Am J Pathol 148:17-23, 1996
21. Van de Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang, PP, Kamel OW: Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. Arthritis Rheum 39:638-642, 1996
22. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: EBV LMP-1 oncogene deletions: correlations with malignancy in EBV-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242-251, 1996
23. Ellman MH, Hurwitz H, Thomas C, Kozloff M: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18:1741-1743, 1991
24. Abdel-Hamid M, Chen JJ, Constantine N, Massoud M, Raab-Traub N: EBV strain variation: geographic distribution and relation to disease state. Virology 190:168-175, 1992
25. Miller WE, Edwards RH, Walling DM, Raab-Traub N: Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75:2729-2740, 1994
26. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM: Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396-1403, 1995
27. Borisch B, Finke J, Hennig I, Delcretaz F, Schneider J, Heitz PU, Laissue JA: Distribution and localization of Epstein-Barr virus subtypes A and B AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 168:229-236, 1992
28. Moorthy RK, Thorley-Lawson DA: All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J Virol 67:1638-1646, 1993
29. Hammerschmidt W, Sugden B, Baichwal VR: The transforming domain alone of the latent membrane protein of the Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 63:2469-2475, 1989
30. Moorthy RK, Thorley-Lawson DA: Biochemical, genetic and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded latent membrane protein LMP-1. J Virol 67:2637-2645, 1993